DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2001 Dr. Jürgen Hans Schmidt From study protocol to final report -practical aspects and constructive input of the DRA/QA function in this process ***
2001 Beate Schmidt-Krauthause Implementation of complaint management in a sales and distribution only company for pharmaceuticals ***
2001 Kirsten Vonde Requirements an opportunities of an OTC-switch – Comparison between Germany, UK and USA ***
2001 Martin Wiesbeck E-Commerce and Homecare in Germany - Opportunities and Limitations
2001 Anette Wiesemann-Fuhr Compare the FDA, EMEA and BfArM internet publication policy especially on approval, pharmacovigilance and Drugs on the horizon ***
2000 Dr. Irmgard Buchkremer-Ratzmann Special features of the development and regulatory requirements of biotechnological products as defined by part A of the Annex of Commission Regulation 2309/93
2000 Dr. Christine Ernst Realisation der Wahrnehmung der Aufgaben des Informationsbeauftragten in einem Vertriebsunternehmen unter Berücksichtigung der Abgrenzung der Aufgabenbereiche des Vertriebsleiters sowie der Schnittstellendefinition mit einem Lizenzgeber und Implementierung in das QS-System ***
2000 Susanne Kästner Review 2000 – Review of Regulatory Procedure by the European Commission ***
  • Total: 968